share_log

Cue Biopharma Q1 EPS $(0.28) Misses $(0.27) Estimate, Sales $1.82M Beat $1.13M Estimate

Benzinga ·  Apr 8 16:06

Cue Biopharma (NASDAQ:CUE) reported quarterly losses of $(0.28) per share which missed the analyst consensus estimate of $(0.27) by 3.7 percent. This is a 3.45 percent increase over losses of $(0.29) per share from the same period last year. The company reported quarterly sales of $1.82 million which beat the analyst consensus estimate of $1.13 million by 61.15 percent. This is a 873.80 percent increase over sales of $187.00 thousand the same period last year.

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more
    Write a comment